Allgens(SH:688613) Sou Hu Cai Jing·2026-02-11 00:41Core Viewpoint - The stock of Aojing Medical (688613) has shown a significant increase, closing at 25.41 yuan on February 10, 2026, with a rise of 5.13% and notable trading activity [1] Group 1: Stock Performance - On February 10, 2026, Aojing Medical's stock price increased by 5.13%, with a trading volume of 115,800 shares and a total transaction value of 289 million yuan [1] - The stock's turnover rate was 8.45%, indicating active trading [1] Group 2: Capital Flow - On February 10, 2026, the net inflow of main funds was 16.23 million yuan, accounting for 5.62% of the total transaction value, while retail investors experienced a net outflow of 25.61 million yuan, representing 8.87% of the total [1][2] - Over the past five days, the stock has seen fluctuating capital flows, with the highest net inflow of main funds recorded on February 9, 2026, at 2.45 million yuan [2] Group 3: Financing and Margin Trading - On February 10, 2026, the financing buy-in was 47.74 million yuan, with a net financing purchase of 9.29 million yuan, marking a cumulative net purchase of 13.24 million yuan over three consecutive days [2][3] - The margin trading balance stood at 235 million yuan, with a short selling volume of 4,771 shares and a remaining short selling balance of 38,300 yuan [3] Group 4: Company Financials and Industry Comparison - Aojing Medical reported a total market value of 3.481 billion yuan, with a net profit of 13.94 million yuan, reflecting a year-on-year increase of 185.19% [5] - The company's gross profit margin is 68.9%, significantly higher than the industry average of 50.61%, ranking 25th in the industry [5] - The company's return on equity (ROE) is 0.98%, which is above the industry average of 0.52%, ranking 89th in the industry [5]